During the past decade, Nemocnice Sokolov conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Sokolov" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Sokolov" are "Diabetic Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Nemocnice Sokolov" in a lesser frequency.

Most popular intervention types in "Nemocnice Sokolov" are "Drug" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials) and "Aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Sokolov" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Sokolov". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nemocnice Sokolov, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Sokolov, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".